Y
Yoni Heisler
Guest
- A new study suggests that the anti-cholesterol drug Fenofibrate, also known as Ticor, can help treat coronavirus patients.
- In lab testing with the drug, the coronavirus completely went away after just five days.
- Clinical trials with Fenofibrate began a few weeks ago and the results should be available in the next few months.
A new research study finds that the drug Fenofibrate -- which is used to help keep cholesterol levels low -- can potentially help treat patients suffering from the coronavirus. The study, which was recently highlighted by Knowridge, relays that the coronavirus typically impacts the body's ability to burn carbohydrates. This, in turn, causes "large amounts of fat to accumulate inside lung cells, a condition the virus needs in order to reproduce."
Indeed, some researchers speculate that this is why people with comorbidities like diabetes and heart disease tend to experience more severe coronavirus symptoms. With this information in tow, researchers from Hebrew University began looking at several FDA-approved drugs designed to combat the accumulation of fat. Before long, researchers began to hone in on Fenofibrate, a drug that's sold under the name Tricor. The drug arrived in the mid-70s and is currently used by upwards of 10 million people with high cholesterol.
Today's Top Deal
Amazon shoppers can't get enough of these best-selling black masks
Price: $26.25
Buy Now
Continue reading...
Today's Top Deals
- 8 coronavirus essentials you should stock up on, according to the CDC
- This top-rated soundbar and wireless sub bundle is down to $110 at Amazon
- Here’s where to pre-order the hot new Pokemon and Mario games for Nintendo Switch
Trending Right Now:
- You won’t believe what the WHO just said about the coronavirus pandemic
- If you haven’t seen this Netflix original series yet, you need to correct that immediately
- Today is your last chance to get a new $600 stimulus check
This common drug might save people with COVID-19 originally appeared on BGR.com on Fri, 15 Jan 2021 at 16:14:36 EDT. Please see our terms for use of feeds.
Via BRG - Boy Genius Report